Your SlideShare is downloading. ×
0
3 Horrendous Healthcare Stocks This Week   2-7-14
3 Horrendous Healthcare Stocks This Week   2-7-14
3 Horrendous Healthcare Stocks This Week   2-7-14
3 Horrendous Healthcare Stocks This Week   2-7-14
3 Horrendous Healthcare Stocks This Week   2-7-14
3 Horrendous Healthcare Stocks This Week   2-7-14
3 Horrendous Healthcare Stocks This Week   2-7-14
3 Horrendous Healthcare Stocks This Week   2-7-14
3 Horrendous Healthcare Stocks This Week   2-7-14
3 Horrendous Healthcare Stocks This Week   2-7-14
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

3 Horrendous Healthcare Stocks This Week 2-7-14

4,962

Published on

Find out which healthcare stocks were the most horrendous performers over the last week.

Find out which healthcare stocks were the most horrendous performers over the last week.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
4,962
On Slideshare
0
From Embeds
0
Number of Embeds
9
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • http://www.fool.com/investing/general/2014/02/06/why-affymetrix-inc-shares-dropped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • Transcript

    • 1. 3 Horrendous Health-Care Stocks This Week
    • 2. It wasn’t just Denver Broncos fans who had a bad week. These three health-care stocks got blown away, too. Source: Wikimedia Commons
    • 3. Affymetrix (Nasdaq: AFFX) Shares of this life-science tools and molecular diagnostic manufacturer tanked more than 23% this week.
    • 4. Why Affymetrix was so horrendous • The company announced disappointing Q4 earnings results after hours on Feb. 5. • Analysts expected adjusted earnings of $0.07 per share, while the actual result was $0.02 per share.
    • 5. Medidata Solutions (Nasdaq: MDSO) The stock of the cloud-based clinical research software developer dropped nearly 18% for the week.
    • 6. Why Medidata was so horrendous • Q4 results were solid, but guidance disappointed. • Full-year earnings were projected at $0.74-$0.79 per share, while analysts expected $0.83 per share. Not a huge miss, but enough to waylay shares of this highly-valued stock.
    • 7. Vanda Pharmaceuticals (Nasdaq: VNDA) The small drugmaker’s shares fell 14% this week.
    • 8. Why Vanda was so horrendous • It won FDA approval on Jan. 31 for Hetlioz in treating a rare sleep disorder that affects blind people. A conference call on Feb. 3 didn’t reveal pricing, but Vanda said the cost would be consistent with other orphan drugs. • Investors were probably nervous about the potential for Hetlioz to be too expensive to win significant market share.
    • 9. Best shot at bouncing back? • The nod goes to Vanda. • There’s a potential U.S. market for Hetlioz of up to 100,000 patients. • Even moderate success for the drug should propel Vanda shares higher. • The key will be how the Hetlioz launch fares in the coming months.
    • 10. Find out which stock The Motley Fool’s chief investment officer selected as the top pick for 2014 in our free report!

    ×